dilazep has been researched along with Cardiac Output, Low in 1 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adenosine is known to be an endogenous cardioprotective substance." | 2.69 | Elevation of plasma adenosine levels may attenuate the severity of chronic heart failure. ( Funaya, H; Hori, M; Kitakaze, M; Komamura, K; Koretsune, Y; Kuzuya, T; Minamino, T; Node, K, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitakaze, M | 1 |
| Minamino, T | 1 |
| Node, K | 1 |
| Koretsune, Y | 1 |
| Komamura, K | 1 |
| Funaya, H | 1 |
| Kuzuya, T | 1 |
| Hori, M | 1 |
1 trial available for dilazep and Cardiac Output, Low
| Article | Year |
|---|---|
Elevation of plasma adenosine levels may attenuate the severity of chronic heart failure.
Topics: Adenosine; Adult; Aged; Cardiac Output, Low; Chronic Disease; Dilazep; Dipyridamole; Humans; Middle | 1998 |